ArticleESMO open2025

Actionable mutations in early-stage ovarian cancer according to the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT): a descriptive analysis on a large prospective cohort.

F Camarda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.